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Abstract: C1q domain-containing (C1qDC) proteins are a group of biopolymers involved in immune
response as pattern recognition receptors (PRRs) in a lectin-like manner. A new protein MkC1qDC
from the hemolymph plasma of Modiolus kurilensis bivalve mollusk widespread in the Northwest
Pacific was purified. The isolation procedure included ammonium sulfate precipitation followed by
affinity chromatography on pectin-Sepharose. The full-length MkC1qDC sequence was assembled
using de novo mass-spectrometry peptide sequencing complemented with N-terminal Edman’s
degradation, and included 176 amino acid residues with molecular mass of 19 kDa displaying high
homology to bivalve C1qDC proteins. MkC1qDC demonstrated antibacterial properties against
Gram-negative and Gram-positive strains. MkC1qDC binds to a number of saccharides in Ca2+-
dependent manner which characterized by structural meta-similarity in acidic group enrichment of
galactose and mannose derivatives incorporated in diversified molecular species of glycans. Alginate,
κ-carrageenan, fucoidan, and pectin were found to be highly effective inhibitors of MkC1qDC activity.
Yeast mannan, lipopolysaccharide (LPS), peptidoglycan (PGN) and mucin showed an inhibitory effect
at concentrations three orders of magnitude greater than for the most effective saccharides. MkC1qDC
localized to the mussel hemal system and interstitial compartment. Intriguingly, MkC1qDC was
found to suppress proliferation of human adenocarcinoma HeLa cells in a dose-dependent manner,
indicating to the biomedical potential of MkC1qDC protein.
Keywords: bivalve mollusk; C1q domain-containing; lectin-like; pattern recognition receptor;
polysaccharides; interstitial compartment
1. Introduction
The specific interaction of proteins with carbohydrate underlies a variety of cell-
to-cell communications and cooperation with extracellular matrix (ECM). Cell surface
forms unique glycosylation patterns, which play a significant role in the immune defense
providing the self and non-self-discrimination abilities. Meanwhile, the most known group
of carbohydrate binding proteins are lectins, which demonstrated diversified affinity to
a variety of carbohydrate determinants. Initially all carbohydrate binding proteins were
recognized as lectins. However, extensive genomic research distinguished separate groups
of proteins recognizing glycans of pathogen-associated molecular patterns (PAMPs) [1].
Among these biopolymers, the C1qDC proteins form very interesting family widespread in
different groups of invertebrates that probably predicts an origin of vertebrates complement
system involved in the immune response.
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In the vertebrates, the C1q protein is a key component of the complement system,
triggering the classical pathway of its activation. In invertebrates, C1q domains and
corresponding proteins show a wide range of ligands, including a variety of PAMPs.
Interestingly, the largest number of genes encoding C1qDC proteins was found in bivalve
species genomes: 337 in Crassostrea gigas [2], 296 in Pinctada fucata [3], 445 in Modiolus
philippinarum [4], 1182 in Ruditapes philippinarum [5], 554 in Saccostrea glomerata [6] and 476
in Crassostrea virginica [7]. This unusually large number of genes probably arose due to
multiple duplications of genomic fragments. Studies suggest that this process occurred
independently in different species [5,7]. Presumably, the abundance of C1qDC proteins
allows covering the protective needs of the bivalve against various pathogens due to
the potential structural diversity of PAMPs. Many bivalve C1qDC proteins are soluble,
secreting PRRs that agglutinate and opsonize foreign agents by PAMPs recognizing [8–12],
but several studies also have shown that they are involved in embryogenesis [9,10,13], shell
formation [14–16] and interaction with predators [14]. Until recent years, some bivalve
C1qDC proteins are classified either as lectins [8,17–19] or as lectin-like proteins, which
emphasizes their probable origin as lectins with subsequent diversification [2,7,20].
Currently, lectins as biomedical and biotechnological tools are a very active area of
research [21–25]. In recent years, great attention has been paid to carbohydrate binding
proteins derived from marine organisms. Bivalves have the most extensive repertoires of
lectins, which allows them to thrive in an environment saturated with pathogens [26]. In
addition to antimicrobial properties, bivalve lectins show promising antitumor and antiviral
activity [22,24]. Bivalve C1qCD proteins are a large group of carbohydrate-recognizing
molecules which are interesting due to functional and property similarities with lectins
and can be a new object of biotechnological usage.
In this work, a novel C1qDC bivalve protein from M. kurilensis (MkC1qDC) was identi-
fied and an effective protocol for its isolation was developed. Immunohistochemical detec-
tion showed intracellular localization of target protein only in hemocytes and MkC1qDC
presence to the hemal system, ECM and interstitial components. The physicochemical
and functional properties of MkC1qDC was characterized, including the carbohydrate
specificity and antimicrobial activity. Furthermore, MkC1qDC demonstrated the inhibition
of HeLa proliferation in a dose-dependent manner, suggesting biomedical potential of this
protein.
2. Results
2.1. MkC1qDC Purification and Electrophoretic Properties
Cell-free hemolymph (plasma) of M. kurilensis is characterized by the highest hemag-
glutination (HA) activity towards human erythrocytes equally for all groups of the AB0
system displaying 1/64–1/256 titers against 6 × 107 cells per mL. Analysis of the carbohy-
drate specificity of M. kurilensis plasma agglutinins by hemagglutination inhibition (HAI)
assay showed that mucins type II and type III, mannan, N-acetyl-D-galactosamine, N-
acetyl-D-glucosamine, sialic acid, D-(–)-ribose, as well as D-glucuronic and D-galacturonic
acids, were inhibitory. Fraction 0–15% of ammonium sulfate precipitation of plasma pro-
teins had no agglutinating activity. Fractions 15−30%, 30−45%, 45−60%, 60−75% and
75−85% had agglutinating activity, but only 60−75% and 75−85% was inhibited by uronic
acids and citrus pectin containing a polygalacturonic acid structure. The inhibition activity
was Ca2+-dependent as 30 mM Na2EDTA disposed of it. Thus, in the presented final
scheme for the isolation of the target protein (Figure 1a), ammonium sulfate precipitation
was reduced to two fractions: 0–60% and 60–85%. Many of the major plasma proteins
(Figure 1b, Lane 1), such as 41 kDa, 36 kDa, 29 kDa and some others, was found only in the
0–60% fraction (Figure 1b, Lane 2), while in the fraction 60–85% there were significantly
fewer bands, but as a result of concentration, a band with a mass of 19 kDa, correspond-
ing to the target MkC1qDC protein, appears (Figure 1b, Lane 3). After chromatography
purification of the 60−85% fraction using pectin-immobilized affinity column (Figure 1c)
the band disappeared in the flow-through (Figure 1b, Lane 4), but was recovered in the
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Ca2+-binding eluate (Figure 1b, Lane 5). Typically, the protein eluted as a narrow peak
upon changing the eluate solution, as noticed by an increase in conductivity (Figure 1c).
On average, we were able to purify 2-4 mg of MkC1qDC from 1000 mL of M. kurilensis
hemolymph plasma.
Figure 1. The scheme of MkC1qDC isolation (a); sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
of samples obtained at different stages of MkC1qDC isolation (b); MkC1qDC band labeled; elution profile of affinity
chromatography on pectin-Sepharose CL-4B (c). 1—cell-free hemolymph; 2—sample after precipitation by ammonium
sulfate 0–60% saturation; 3—second precipitation by ammonium sulfate before affinity chromatography; 4—flow-through
of affinity chromatography; 5—eluted fraction; Mr—molecular weight standards.
2.2. Sequencing Analysis
We initially sequenced the protein by Edman sequencing. MkC1qDC samples were
purified independently at five different time points, and we were able to sequence 13 to
41 residues (Figure 2a). However, we were unable to find any significant matches against
any of the public databases when using the Basic Local Alignment Search Tool (BLAST,
https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 26 May 2021).
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Figure 2. Amino acids sequencing of MkC1qDC: N-terminal peptides from Edman’s degradation (a); alignment of two
fragments obtained by mass-spectrometric de novo sequencing (b) identical to Edman’s degradation results (c); alignment
of three de novo peptides (d) that had high quality of matches with C1qDC or C1q-like proteins from other Bivalvia (e);
alignment of full-length MkC1qDC sequence assembly with nearest homologues (f).
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To complement the data, we applied de novo mass spectrometry peptide sequencing
to determine the amino acid sequence of the protein. The purified protein was digested
with trypsin and several peptides of up to 50 residues with an Average Local Confidence
>80% were identified. Analysis of these fragments allowed us to assemble a sequence that
matched to data obtained by Edman sequencing (Figure 2b,c). In addition, a 70 amino acids
sequence was generated by alignment of three overlapping peptides (Figure 2d). Analysis
of this fragment by BLAST found a match with C1qDC or C1q-like proteins of Bivalvia with
high statistical significance and up to 67% identity for CBX41653.1 (Figure 2e and Figure S1).
The full-length MkC1qDC sequence (Figure S2) was subsequently assembled using the
longer stretches obtained by using the de Bruijn assembler ALPS [27] and CBX41653.1 as
a reference. Analysis of assembled MkC1qDC sequence by BLAST detected a putative
conserved C1q superfamily domain and high homology to other Bivalvia C1qDC proteins:
CBX41653.1; CAC5364865.1; CAG2251157.1; XP_022294274.1; XP_034307311.1 (Figure 2f).
The homologous proteins had one C1q domain at the C-terminus, a short unique N-
terminus and were in the range of 177−206 residues. Full-length MkC1qDC has 176 amino
acids in length, a predicted molecular weight of 19181 Da and a pI 5.2.
2.3. Physicochemical Properties
To further explore the properties of MkC1qDC we used 2D electrophoresis. Purified
MkC1qDC was found to be a single polypeptide with a molecular mass of 19 kDa mass
(Figure 3a) and a pI of 5.2, both of which match the theoretical pI and molecular weight.
Purified MkC1qDC had high agglutinating activity after incubation for 1 h at temper-
atures of 0–40 ◦C, which slightly decreased at 50 ◦C, and were completely lost at 60 ◦C or
higher (Figure 3b). At the same time, the maximum HA activity was detected after 1 h
of incubation in the pH range of 7–8 (Figure 3c). Increasing the pH to nine led to a slight
decrease in activity and no activity was detected above pH 10. Acidic solutions up to pH 3
had only a weak effect on HA activity, indicating the wide range of pH stability.
Figure 3. Basic physicochemical properties of the MkC1qDC: 2D electrophoresis of purified MkC1qDC (a); the activity after
1 h of incubation at different temperatures (b) or pH (c). HA: hemagglutination.
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2.4. Carbohydrate Specificity
The highest MkC1qDC agglutination activity was against human erythrocytes with
no prevalence with respect to blood group. Therefore, all succeeding experiments was
performed only with human group 0 erythrocytes.
Among 23 monosaccharides tested by the HAI assay, only six were inhibitory (Table 1).
L-gulose, sialic (N-acetylneuraminic), D-galacturonic and D-glucuronic acids showed the
highest inhibitory effect among monosaccharides with half maximal inhibitory concen-
tration (IC50) in the range of 1.16–1.46 mg/mL. D-galactose and 2-deoxy-D-galactose
were effective in the range of 2.46–5.4 mg/mL. Furthermore, disaccharides such as 2α-
mannobiose and D-lactose were noted as inhibitory molecules displaying IC50s starting
from 5.13 mg/mL. Mannan from Saccharomyces cerevisiae, LPS from Escherichia coli, PDG
from Staphylococcus aureus and mucin type II from porcine stomach were moderately in-
hibitory at concentrations three orders of magnitude greater than for the most effective
saccharides (0.10–0.49 mg/mL). Alginate, κ-carrageenans, fucoidan and citrus pectin were
highly effective inhibitors characterized by the lowest IC50 (less than 0.002 mg/mL).
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2.5. Bacterial Agglutination and Antimicrobial Activity
MkC1qDC had antibacterial activity against both Gram-positive (Bacillus subtilis, S.
aureus) and Gram-negative (Vibrio sp., Ruegeria sp., E. coli, Pseudoalteromonas sp.) bacteria
(Figure 4). At the same time, agglutination occurred most effectively in the cases of
Pseudoalteromonas sp. and B. subtilis, which in the presence of MkC1qDC formed the largest
conglomerates, in contrast to Vibrio sp., which were united into small sparse groups of
4–15 cells. In addition, MkC1qDC showed bacteriostatic properties against most of the
above strains as significant growth suppression started after 4–12 h (p < 0.05). The only
exception was Vibrio sp. The decrease in the density of the Vibrio sp. cultures in the presence
of MkC1qDC occurred only after 26 h of cultivation (p < 0.05) when the control was in a
stationary phase (Figure 4).
2.6. Antibody Production and Immunohistochemical Localization of MkC1qDC in Mussel Tissues
To further characterize MkC1qDC polyclonal antibodies were raised in rabbits. The
antibody reacted strongly with purified MkC1qDC as well as a polypeptide with the same
molecular weight in the plasma of M. kurilensis (Figure 5a,b). The upper ~40 kDa band
appeared to be an incompletely dissociated dimer, as evidenced by its molecular weight,
an increase in this fraction during storage and the disappearance of the component when
2-mercaptoethanol is replaced by dithiothreitol. Finally, antisera and purified immunoglob-
ulin G fraction were tested in indirect enzyme-linked immunosorbent assay (ELISA) and
Western blotting, and proved to be suitable for an investigation of tissue-specific MkC1qDC
localization taking 1/500 dilution as a working titer.
The intracellular localization of MkC1qDC was most obvious in hemocytes (Figure 5c).
A subset of the large cells had stained granules that could occupy almost the entire cyto-
plasm. In contrast, most of the agranulocytes and all small juvenile hemocytes were not
stained. Control samples with pre-immune rabbit serum treatment showed no staining
(Figure 5d).
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Figure 4. Antibacterial properties of MkC1qDC (0.1 mg/mL) against paraformaldehyde fixed FITC-
labeled bacteria (a), and live bacterial cultures (b). The data on the graphs are presented as a
mean ± 95% confidence interval. Scale bars: 10 µm.
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Figure 5. Detection of MkC1qDC (narrow labeled) in the components of M. kurilensis hemolymph: in plasma (a,b) and
in hemocytes (c,d). (a) Electrophoresis; (b) Western blotting (1—purified MkC1qDC; 2—plasma; Mr—molecular weight
standards); (c1,c2) treatment with MkC1qDC antibodies; (d1,d2) control with pre-immune rabbit serum. Nuclei are colored
in blue by DAPI. Scale bars: 10 µm.
In paraffin sections MkC1qDC was found in structures associated with the hemal
system (Figure 6). The protein was mainly in hemocytes and the walls of hemal sinuses
and vessels, as well as in the ECM of connective tissue and interstitial space. Gills were
one of the organs expressing the highest levels of the protein. Intense immunofluorescent
staining was well defined to the walls of bronchial sinuses inside the ctenidia. Moreover,
hemocytes that were present in large numbers inside the sinus, including the abfrontal
narrowing, were brightly stained and stood out, particularly compared to other organs
(Figure 6a). Mantle, another organ with massive contact with the water environment,
had some differences with respect to MkC1qDC localization. As in the previous case,
staining was detected along the walls of the hemal sinuses and in the hemocytes located
inside them. In addition, intensely stained hemocytes were found in the epithelial wall of
the papillae. However, fibrous components were stained most evidently in the marginal
zone of the mantle (Figure 6b). The distribution pattern of MkC1qDC in the internal
epithelium of different parts of the intestine was identical: the walls of hemal sinuses and
hemocytes located inside them or intercalated in between cells of the internal epithelium
were stained most intensely (Figure 6c). The digestive gland of M. kurilensis, which is
formed by the digestive tubules surrounded by the interstitium, hemocytes, as well as the
walls of the interstitial space and fibers of relatively large fibrous formations, were positive
for MkC1qDC (Figure 6d). The staining for MkC1qDC was weak in the kidney tubules,
formed by nephrocytes with concretions and large vacuoles, while the relatively narrow
interstitial space between the tubules, filled with fibrous tissue with hemocytes, was stained
more intensely. In addition, the walls of concretions, which contain collagen, had slightly
more intense staining compared to the control (Figure 6e). In gonads, which are mainly
filled with gametes in different stages of development, intense fluorescence was confined
to the interstitial space formed by the connective tissue, in which the walls and hemocytes
were best stained (Figure 6f). In general, the intensity of the signal in the pericardium
was intense, which might be explained by the abundance of hemal canals and hemocytes
located within. Additionally, the pericardial epithelium was characterized by slightly more
intense fluorescence (Figure 6g). Analysis of the posterior adductor muscle also showed
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the presence of MkC1qDC at the edge of the hemal vessels and in the hemocytes located
inside them with a slight color of the tissue (Figure 6h).
Figure 6. The MkC1qDC localization in organs of M. kurilensis: (a1,a2) gills; (b1,b2) mantle; (c1,c2) intestine; (d1,d2)
digestive gland; (e1,e2) kidney; (f1,f2) gonad; (g1,g2) pericardium; (h1,h2) muscle; (a1–h1) fluorescence with phase contrast;
(a2–h2) fluorescence only. Abfrontal zone: az; acinus: a; hemocytes: h; hemal sinuses/vessels: hs; intermediate zone: iz;
bronchial sinus: bs; interstitial space: is; concretions: c; lateral zone: lz; muscle fibers: mf ; nephrocytes: n; digestive tubule:
dt; connective tissue fibers: ctf ; epithelium: e. Scale bars: 20 µm.
2.7. Antiproliferative Activity on HeLa Cell Line
Finally, we tested if MkC1qDC may have antiproliferative activity in a mammalian
context. To determine this, we monitored HeLa proliferation using high-content, time-
lapse microscopy. We used a machine-learning algorithm to segment individual cells
and determined cell proliferation in the presence or absence of MkC1qDC. Significant
differences between control and treated groups were detected after 4 h (4 µg/mL of
MkC1qDC) or 16 h (1 and 2 µg/mL) (Figure 7). Further analysis showed that MkC1qDCa
elicited a dose-dependent antiproliferative effect. At the highest concentration, we detected
next to no cell proliferation and most cells displayed morphology akin to dead cells.
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Figure 7. The MkC1qDC effect on HeLa cell line proliferation. Time-lapse cell monitoring and dynamic count based on
Cell iQ machine learning during 90 h MkC1qDC treatment (a); the HeLa cell cultures after 90 h cultivation with MkC1qDC
concentrations 0 µg/mL (control, b), 1 µg/mL (c), 2 µg/mL (d) and 4 µg/mL (e). Scale bars: 50 µm.
3. Discussion
Using a HAI technique to study the carbohydrate specificity of the M. kurilensis plasma,
we observed a strong inhibitory effect on D-glucuronic acids. Earlier, in a closely related
species Modiolus modiolus, the same analysis did not reveal the same specificity [28]. Lectins
modiolin H and E isolated from M. modiolus had a different molecular weight [28,29] from
lectin-like MkC1qDC observed in this study (Figures 1b and 3a). Obtaining N-terminal
sequence of 41 amino acids, any significant homology matches were not identified, which
indicates the uniqueness of the protein’s N-terminus. All obtained data indicate that a new
protein with unique carbohydrate-recognizing properties has been isolated. From mass
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spectrometry and de novo assembling we observed the full-length MkC1qDC sequence
with high similarity to MgC1q4 (Figure 2d–f). We find out that MkC1qDC has similar
structure to the group of Bivalvia sialic acid-binding lectins determined as C1qDC [30].
Moreover, molecular weight and pI of MkC1qDC were very similar to that of other globular
head C1qDC bivalve proteins isolated from Chlamys farreri (CfC1qDC) and Argopecten
irradians (AiC1qDC-1) [8,9].
C1qDC proteins have been found to be immune factors in many cases. Various
pathogens and their components induce an increase in C1qDC proteins expression, as
well as C1qDC proteins demonstrating the ability to bind PDG, LPS, poly I:C, man-
nan, β-1,3-glucan, yeast glucan and live bacteria, generally indicating their role as PRRs
[9–13,18–20,31–38]. Agglutinating activity of MkC1qDC was observed against Gram-
positive and Gram-negative bacteria, but with slightly more pronounced selectivity for
certain strains, such as Pseudoalteromonas sp. and B. subtilis (Figure 4). Agglutinating activ-
ity similar to that discussed in this study was observed for recombinant proteins from C.
farreri (CfC1qDC) and A. irradians (AiC1qDC-1, AiC1qDC-2) scallops [8,9,11]. Interestingly,
HA correlates with the content of the 19 kDa polypeptide in the M. kurilensis plasma [39],
which probably means the importance of MkC1qDC as a soluble PRR with agglutinating
function.
It is currently known that C1qDC proteins in the bivalve can be expressed in in
all organs [8,16,17,20,37], especially in hepatopancreas [9,11,19,33], hemocytes [12,13,40],
mantle [12,18] and gills [19]. However, transcription in hemocytes invariably increased
upon immune stimulation. This fact indicates the clearly inducible nature of C1qDC
synthesis and their involvement in the immune response with hemolymph. MkC1qDC
was found in all organs of the mollusk; however, the only structures with intracellular
localization were hemocytes (Figure 5), which are ubiquitous in the elements of the hemal
system or sometimes migrate in the epithelium of the mantle and the intestine. In all other
cases, MkC1qDC was associated with extracellular structures, mainly with the walls of the
hemal system and interstitial space, as well as with ECM fibers (Figure 6). Organs with
the highest expression are the gills, the edge of the mantle and the pericardium—these are
tissues with the highest exposure to pathogens. Thus, it can be assumed that the main cells
synthesizing MkC1qDC are hemocytes, and due to good solubility, it circulates throughout
the body and further can be fixed on the components of the extracellular matrix, performing
immune or other possible additional functions.
The role of C1qDC proteins as PRRs implies their specificity for various PAMPs; this
study also showed the high sensitivity of MkC1qDC towards mannan, LPS and PDG
(Table 1). However, the specificity toward alginate, κ-carrageenan, fucoidan and pectin
was significantly higher, making MkC1qDC protein characterized by most pronounced
specificity to glycans enriched with acid galactans and mannans. These polysaccharides are
mainly components of algal cell walls, which explains some of their structural similarity.
Besides their obvious feeding role, microalgae can be invasive in bivalve and initiate
some pathogenicity processes. In particular, earlier this was shown for M. kurilensis and
Coccomyxa parasitica [41]. At the same time, for Chlorophyta the content of alginate and
pectin in the cell walls is known [42]. Regarding selectivity to monosaccharides, the
affinity of bivalve C1qDC proteins for sialic acid was only shown [17,18,30], while in the
current study the highest activity was detected for sialic acid, but also for other acetylated
monosaccharides such as uronic acids, as well as for D-galactose, 2-deoxy-D-galactose,
L-gulose and disaccharides D-lactose and 2α-mannobiose. At the same time, many lectins
showed the wide spectrum of carbohydrate specificity, especially for oligosaccharide with
different structures [43,44]. It was also demonstrated that point amino acid substitutions in
the carbohydrate-recognition domain of C-type lectin can lead to a significant change in
affinity from mannose to methyl L-fucosides [45] or galactose [46] as well as a ricin-B chain-
like galactose-binding protein which was obtained from sialic acid-binding lectin [47].
The range of carbohydrate specificity determines the potential in the use of lectins
and lectin-like proteins in biotechnology and biomedical science. During tumor cells
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transformation, a change in the carbohydrates types of their surface occurs. Therefore, the
lectins and lectin-like proteins that are able to recognize particular carbohydrate patterns
also show antitumor activity. Impotence of cell surface sialylation in tumorigenesis and
metastasis was known for a long time [48,49]. The sialic acid-binding lectin from the
mollusk Haliotis discus discus, which is also a representative of the C1qDC proteins [30],
possesses pronounced antitumor properties [50–52]. Other important saccharides for
tumorigenic cell surface alteration are mannosides [53]. Hence, the mannose binding
lectin was already used in designing a selective drug delivery system [54,55]. Additionally,
oncodiagnostic applications of different lectins with affinity to β-branched galactosides,
mannosides, as well as to sialylation and fucosylation glycoconjugates, was shown [56,57].
In the current study, MkC1qDC, which showed sialic acid binding lectin-like activity and
the highest affinity to acidic galactans and mannans, significantly inhibited the growth of
HeLa at the concentration 1 mg/mL, while at 4 mg/mL caused death of most of the cells,
resulting in the absence of the significant growth of cell line even after 90 h of cultivation
(Figure 7). This result is only a preliminary indicator of the biomedical potential of the new
protein, and further analysis should include the study of both normal and cancer cell lines
in order to identify the mechanisms of the antiproliferative activity of MkC1qDC.
Thus, this study first described a novel C1qDC protein, which has immune functions
and is associated with the hemal system and interstitial compartment of the marine mollusk
M. kurilensis. The PRR properties such as antibacterial activity and interactions with PAMPs
(mannan, LPS, PDG) were observed. At the same time, agglutination activity and growth
inhibition of bacteria had various effects on different strains, although MkC1qDC properties
were not associated with their Gram classification. The investigated range of carbohydrate
affinity of C1qDC protein has a unique character that, together with its ability to inhibit
the growth of the HeLa cells, indicates possible implementation of MkC1qDC protein in
biotechnology and biomedicine. Taking into account that the MkC1qDC protein is capable
of recognizing acidic galactans and mannans, it may be of interest for creating systems
for targeted delivery of therapeutic agents to cancer cells, and can also be included in
diagnostic kits for phenotyping the cell surface carbohydrate profile. This is of interest for
further research and development involving both native and recombinant MkC1qDC.
4. Materials and Methods
4.1. Purification and Electrophoretic Properties of the MkC1qDC
The MkC1qDC was purified from cell-free hemolymph (plasma) of M. kurilensis.
Healthy adult mollusks with shells over 70 mm in length were selected from Peter the
Great Bay, Sea of Japan (42.892078◦ N, 132.737502◦ E and 43.200788◦ N, 131.914084◦ E).
Hemolymph was isolated immediately from the hemal sinus of the dorsal adductor muscle.
Cells were removed by centrifugation for 15 min at 4 ◦C and 300× g. Plasma from different
individuals was mixed, clarified by centrifugation for 30 min at 4000× g and 4 ◦C and
stored at −80 ◦C until the next stage.
The isolation of MkC1qDC was carried out in a few steps. Firstly, ammonium sulfate
precipitation [58] of M. kurilensis plasma proteins with 0−15%, 15−30%, 30−45%, 45−60%,
60−75% and 75−85% salt saturation at 0 ◦C was produced. Protein coagulates were
centrifuged for 30 min at 4000× g and 0 ◦C to precipitate. The obtained precipitates were
dissolved in Tris buffer saline (TBS: 10 mM Tris-HCl, 150 mM NaCl, pH 7.5), dialyzed
against a large volume of TBS three times at 4 ◦C, clarified by centrifugation (30 min,
10,000× g, 4 ◦C) and added CaCl2 up to 15 mM just before using. The target activity
was determined by hemagglutination assays described below, and included inhibition by
uronic (D-glucuronic, D-galacturonic) acids and adding chelants (EDTA, and EGTA) for
Ca2+-dependence determination.
Citrus pectin (Copenhagen Pectin A/S) covalently linked to Sepharose CL-4B (Sigma-
Aldrich, St. Louis, MO, USA) by divinyl sulfone (Sigma-Aldrich, St. Louis, MO, USA) was
applied for affinity chromatography on the final purification step. Loading of prepared
fractions with target activity and column washing from unbound components was per-
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formed in TBS with 15 mM CaCl2. The elution was carried out with a large buffer solution
containing a chelant (200 mM Tris-HCl, 150 mM NaCl, 30 mM Na2EDTA, pH 7.5). All
stages were performed with the flow 0.2 mL/min. The eluate was dialyzed against TBS at
4 ◦C and divided into aliquots containing 100 µg of protein in cryovials, which were frozen
and stored in liquid nitrogen at −196 ◦C.
Protein concentration was determined by the Bradford method [59], using BSA as
standard, and measured by NanoPhotometer P360 (Implen) at a wavelength of 595 nm.
To analyze the quality of protein isolation at each stage, SDS-PAGE based on 12% poly-
acrylamide gel stained with Coomassie Brilliant Blue G-250 solution was produced [60].
The isoelectric point (pI) and composition of the purified MkC1qDC were determined
by 2D electrophoresis using ReadyStrip™ IPG strips pH of 4−7 (Bio-Rad, Hercules, CA,
USA) in the first dimension and a gradient of 4−20% polyacrylamide gel in the second
dimension.
4.2. Amino Acid Sequencing
N-terminal sequencing was performed according to Edman’s degradation method [61]
by a Procise 492 Protein Sequencer (Applied Biosystems, Waltham, MA, USA), using the
manufacturer’s protocol.
For mass spectrometry, MkC1qDC was dissolved in 6 M guanidinium-HCl, 100 mM
Tris pH 8, 10 mM chloroacetamide, 5 mM Tris (2-carboxyethyl) phosphine hydrochlo-
ride, heated at 95 ◦C for 5 min. The sample was diluted with water 10-fold and 1/100
trypsin/substrate was added. Digestion was performed at 37 ◦C for 4 h. The digest
was acidified to 1% trifluoroacetic acid final concentration, spun at 15,000× g for 10 min
and desalted on homemade C18 stage tips as described previously [62]. Peptides were
analyzed on a Fusion Lumos mass spectrometer (Thermo Fisher Scientific, Milan, Italy)
coupled to an RSLnano uHPLC pump (Thermo Fisher Scientific, Milan, Italy). Peptides
were separated on a 15 cm C18 Aurora column (IonOptiks, Victoria, Australia) using a
40 min gradient from 5−35% acetonitrile with 0.05% acetic acid. The instrument was
operating in a high/high mode with a resolution of 120k/35k (MS and MS/MS). De novo
sequencing was performed using the PEAKS software suite (Bioinformatics Solutions)
with 5 ppm/0.01 Da mass accuracy (MS and MS/MS). Cysteine carbamylation fixed and
Methionine oxidation (Variable) were selected as modification; trypsin was selected as
protease with 2 missed cleavages. The list of peptides was trimmed using a cut-off of 80%
Average Local Confidence Score. These high-confidence peptides were assembled into
longer stretches using ALPS, a de Bruijn assembler, using a k-value of 7 as described [27].
This resulted in the assembly of 11 protein sequences. Initial BLAST searching against a
non-redundant Bivalvia sequence database revealed a significant homology to CBX41653.1.
Therefore, it was used as a template to stitch the peptides together by aligning them to
CBX41653.1 using Clustal Omega [63]. The theoretical molecular weight and pI of as-
sembled MkC1qDC were determined by ExPASy (http://web.expasy.org/compute_pi/,
accessed on 26 May 2021).
4.3. Hemagglutination, Carbohydrate Specificity Assay, pH and Temperature Effects
Hemagglutination (HA) was performed as described previously [64], using fixed
human (0, A, B, AB), rabbit, rat and sheep erythrocytes. In the case of purified MkC1qDC
the protein concentration of 0.1 mg/mL was used.
To investigate the carbohydrate specificity of MkC1qDC, a hemagglutination inhi-
bition (HAI) test with the presence of one of 41 different saccharides was performed, 12
of which were polymers, 6 were oligomers and others were monomers (Table 1). Each
carbohydrate was used in a series concentration of two-fold dilutions from 30 to 0.0029
mM (for polymers, concentration was calculated based on average monomers weight), and
the inhibitory effect was determined by a decrease in the lectin HA activity (titer decline
for one 2-fold dilution).
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Isotonic (150 mM NaCl) buffer solutions were used to determine the pH dependence:
glycine-HCl (pH 3), sodium acetate-acetic acid (pH 4, pH 5), sodium cacodylate-HCl
(pH 6, pH 7), Tris-HCl (pH 8), glycine-NaOH (pH 9) and carbonate-bicarbonate (pH 10)
at a concentration of 20 mM. HA activity was checked after 1 h of incubation at room
temperature in TBS/Ca2+ with high buffering capacity (50 mM Tris-HCl, 150 mM NaCl,
15 mM CaCl2, pH 7.5).
To study the thermal lability, MkC1qDC samples were incubated for 1 h at temper-
atures of 0, 10, 20, 30, 40, 50, 60 and 70 ◦C and then were brought to room temperature
before HA reaction.
4.4. Bacterial Agglutination and Bacteriostatic Assays
Gram-negative (Vibrio sp., Ruegeria sp., E. coli, Pseudoalteromonas sp.) and Gram-
positive (S. aureus, B. subtilis) bacteria from marine organisms were used for analysis.
Strains grew for 2-4 days to log-phase at room temperature in the liquid medium based on
sterile-filtered sea water [65].
Agglutination assay was performed as described previously [66] with some modifi-
cations. After that, growing bacteria were collected by centrifugation (3000× g, 20 min
at 4 ◦C), washed three times with HEPES buffer saline (HBS: 0.1 M HEPES-NaOH, 1.5 M
NaCl, pH 7.4) and fixed by 4% PFA solution in HBS. Next, bacterial cells were stained with
a fluorescent dye Fluorescein isothiocyanate (FITC, Thermo Fisher Scientific, Milan, Italy)
with a final concentration of 0.1 mg/mL, vortexed at 800 rpm for 1 h, and washed 3 times
in HBS. The stained suspensions with a final optical density (A600) of 1 were mixed in HBS
with 50 mM CaCl2 and 0.1 mg/mL MkC1qDC, or without it as control (3 replicates for
each condition). The mixtures were vortexed at 100 rpm for 1 h at room temperature. Visu-
alization was performed using laser scanning microscope FV1200MPE-FV12M-5XX-3XX
(Olympus).
For the evaluation of MkC1qDC antimicrobial activity, bacteria were diluted in poor
broth medium (PBM: 1.5% peptone, 1.5% NaCl, pH 7.2) to A600 = 0.05 and 50 µL placed
into each well of the 96-well flat-bottom microplate. Then 50 µL of 0.2 mg/mL MkC1qDC
solution in PBM was added in experimental wells, or 50 µL PBM as a positive growth
control, or 50 µL antibiotic solution (penicillin 2000 units/mL and streptomycin 2 mg/mL)
in PBM as negative control (6 replicates for each condition). The results of bacterial growth
inhibition were estimated at 600 nm using the Cytation 5 Cell Imaging Multi-Mode Reader
(BioTek). The inhibition efficiency was evaluated by the delay time in the bacteria growth
in the presence of lectin vs the positive control.
4.5. Preparation and Validation of Polyclonal Antibodies
The commonly used immunization protocols [67] with some modifications were
employed to generate the rabbit polyclonal antibody to MkC1qDC. Briefly, the first intra-
muscular injection of purified MkC1qDC was performed with complete Freund’s adjuvant;
then two consecutive injections of the immunogen with incomplete Freund’s adjuvant
were given at intervals of 20 and 60 days, respectively; the boost was carried out in 14 days
by a subcutaneous injection of MkC1qDC in sterile TBS. Each injection contained 250 µg of
purified MkC1qDC. Blood was taken 10-14 days after each injection from the ear vein, and
the isolated serum was stored at –80 ◦C.
The immunoglobulin fraction was purified by standard protocol [68] using ammonium
sulfate precipitation and Sephadex G-25 (GE Healthcare, Chicago, IL, USA) gel filtration
for desalting.
Primary antibody activity was measured by the commonly used protocol of in-
direct ELISA [69] with horseradish peroxidase-conjugated secondary antibody and o-
phenylenediamine as substrate. Results were detected by iMark Microplate Absorbance
Reader (Bio-Rad, Hercules, CA, USA) at 492 nm.
In addition, antibody validation using Western blotting was performed by Mini
Trans-Blot®Module for Mini-PROTEAN®Tetra Cell (Bio-Rad, Hercules, CA, USA). After
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electrophoresis, samples were transferred onto the PVDF membrane and placed for 2 h in
a 3% BSA solution in TBS with 0.05% Tween-20 (TBST). The purified primary antibody was
used at 1/2500, 1/5000 and 1/10000 dilutions (calculated based on ELISA result) in 0.5%
BSA prepared on TBST, followed by incubation at 23 ◦C for 2 h. Then it was incubated with
mouse antirabbit secondary antibody conjugated with horseradish peroxidase (Thermo
Fisher Scientific, Milan, Italy) at 1/20000 dilution in TBST, and incubated for 1 h at 23 ◦C.
After that, a substrate for chemiluminescent staining Pierce ECL Plus Western Blotting
Substrate (Thermo Fisher Scientific, Milan, Italy) was applied to the membrane according
to the industrial protocol. The result was recorded on a ChemiDoc Touch Imaging System
(Bio-Rad, Hercules, CA, USA). Analysis was performed using native M. kurilensis plasma
and purified MkC1qDC as samples.
4.6. Immunohistochemistry and Protein Localization
Tissue fragments of the intestine, mantle, muscle, pericardium, gills, gonads, digestive
gland and kidney were excised and immediately fixed for 2 h in paraformaldehyde (PFA)
solution in phosphate buffered saline (PBS: 10 mM Na2HPO4-KH2PO4, 137 mM NaCl,
2.7 mM KCl, pH 7.4), washed 10 times in PBS and dehydrated through a progressive series
of ethanol, infiltrated by xylene and embedded in paraffin. Tissue sections with a thickness
of 10 µm were obtained using an HM-360 rotary microtome (MICROM International GmbH,
Germany). The paraffin sections were dewaxed and washed 3 times in PBS with 0.05%
Tween-20 (PBST) with further staining without drying.
Suspension of live hemocytes was obtained as previously described [64], diluted in
RPMI-1640 culture medium (PanEco, Tokyo, Japan) and placed in an 8-well chamber (Ibidi
GmbH, Gräfelfing, Germany) for 30 min at 10 ◦C for their adhesion. Then the cells were
fixed for 10 min at 23 ◦C by adding a 16% PFA in artificial sea water (ASW: 460 mM NaCl,
9.4 mM KCl, 48.3 mM MgCl2, 6 mM NaHCO3, 10.8 mM CaCl2, 10 mM HEPES, pH 7.5)
directly to the culture medium to a final concentration of 1.5%. Then the liquid was taken
from the wells, 300 µL of cold methanol was added to them and left at 4 ◦C for 10 min,
after which the chamber was left for longer storage at –20 ◦C. Immediately before staining,
hemocyte preparations were washed 3 times with PBST solution.
Further, in order to permeabilize the membranes, PBS with 0.5% Triton X-100 was
applied to the sections and hemocytes for 10 min at 23 ◦C. The primary antibodies in PBS
with 0.5% BSA at a dilution of 1/500 were incubated with preparations for 2 h at 23 ◦C;
secondary goat antibodies conjugated with Alexa Fluor-488 (Thermo Fisher Scientific,
Milan, Italy) with the same dilution were incubated for 1 h at 23 ◦C; nuclei were stained
by DAPI (4,6-diamino-2-phenylindole, dihydrochloride; Invitrogen) with a concentration
of 1 µg/mL in PBS for 5 min at 23 ◦C. Between all steps, samples were washed 3 times
for 10 min in PBST and, after the last step of staining, embedded in the water-soluble
medium Mowiol 4-88 (Sigma-Aldrich, St. Louis, MO, USA). The described procedure
with pre-immune rabbit serum as primary antibody was used as a control. The samples
were analyzed using FluoView FV1200MPE-FV12M-5XX-3XX laser scanning microscope
(Olympus).
4.7. Human Cell Culture and Proliferation Assay
Cell proliferation assay was performed using a high-content imaging system Cell-
iQ MLF (CM Technologies). Human adenocarcinoma cell line HeLa (ATCC) was plated
in tissue-culture grade 24-well plates at a density of 15,000 cells/cm2. The cells were
cultured at 37 ◦C and 5% CO2 in Dulbecco’s Modified Eagle’s medium (DMEM, Gibco)
supplemented with 10% FBS. The cells were cultured for their adhesion and growth
stabilization for 18 h, then treated with 1, 2 and 4 µg/mL of MkC1qDC and monitored for
90 h applying time-lapse phase-contrast imaging. Untreated wells were utilized as a control
sample group. All series were cultivated and analyzed in six replicates. Cell proliferation
data are presented as growth curves indicating total cell count produced automatically
based on machine learning.
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4.8. Experimental Design and Statistical Rationales
Proteomics experiments were conducted on one purified protein sample. For the
analysis of MkC1qDC effect on bacteria and HeLa growing, the Mann–Whitney U test and
Kruskal–Wallis H test were used. A p-value less than 0.05 was considered to be statistically
significant. Experimental results are presented as a mean ±95% confidence interval.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/md19120668/s1, Figure S1: Mass spectrometry data of peptides using for alignment with
N-terminus peptides obtained by Edman’s degradation (a, b) and for construction 70 amino acids
sequence (c–e) with high homology to Bivalvia C1qDC proteins (see Figure 2), Figure S2: The
full-length MkC1qDC amino acids sequence in fasta format.
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